Skip to main content
Sponsored

European legislation must be revised to boost innovation in rare disease

This article has been developed and funded by Chiesi Group Rare Diseases.  Inflation and rising public debt are creating barriers for the rare disease community to access the latest therapies. Public healthcare budgets are being reduced, making access to new treatments difficult while stricter evidence requirements further limit availability across Europe. The lack of treatment … Continued
Rare Diseases 2025

Protected: Gain insights from the largest orphan drug and rare disease event globally

There is no excerpt because this is a protected post.
Rare Diseases 2025

Protected: Rare diseases and health equity: shifting the paradigm through global action

There is no excerpt because this is a protected post.